A South Florida Research Site Built for
Endocrine, Metabolic and Primary Care Studies
Navia’s Clinical Research is an independent adult outpatient clinical research site in North Lauderdale, Florida. We support Phase II–IV interventional and observational studies across endocrinology, diabetes, obesity, metabolic disease, thyroid disorders, family medicine and related cardiometabolic indications.
Site Overview
Why Navia’s Clinical Research
We reduce enrollment uncertainty in adult endocrine and primary-care trials through direct PI access, bilingual recruitment and protocol-specific cohort validation.
Direct investigator alignment
Endocrinology and family-medicine protocols are reviewed by the Principal Investigator whose expertise most closely aligns with the indication and standard-of-care pathway.
Bilingual clinical operations
English- and Spanish-speaking investigators and site personnel support recruitment, consent discussions, study visits, safety follow-up and participant retention.
South Florida patient access
Potential participants may be identified through investigator practices, physician referrals, affiliated adult-care settings, community outreach and protocol-approved digital recruitment.
Dedicated outpatient research site
The site provides a dedicated setting for scheduled outpatient research visits without reliance on a hospital research department.
Clinical and laboratory capabilities
On-site capabilities include phlebotomy, specimen processing, ambient and refrigerated centrifuge, temperature-controlled storage and 12-lead ECG assessments.
Direct site leadership
Single-location leadership supports efficient communication during feasibility, startup and operational issue escalation.
Therapeutic Focus
Endocrinology
Type 1 and Type 2 diabetes
Obesity and weight management
Metabolic disease
Thyroid disorders
Hypertension
Dyslipidemia
Family medicine
Adult primary care
Cardiometabolic conditions
Adult vaccine studies
Additional indications and protocol requirements are evaluated on a study-specific basis.
Principal Investigators
Coromoto Angela Palermo, MD
Dr. Palermo is board-certified in Endocrinology, Diabetes and Metabolism and has an Internal Medicine background. Her clinical and research experience includes diabetes, insulin therapy, thyroid disease, metabolic disorders, resistant hypertension and related endocrine conditions. Her South Florida clinical practice supports protocol-specific patient identification and referral pathways.
Alfredo Lam, DO
Dr. Lam is board-certified in Family Medicine, with research experience across obesity, type 2 diabetes, hypertension, dyslipidemia, adult vaccines and related cardiometabolic conditions. His experience includes studies involving retatrutide, cagrilintide with semaglutide, semaglutide, baxdrostat, inclisiran and the mRNA-1083 combined influenza and COVID-19 vaccine.
Patient Access & Recruitment
Located in North Lauderdale, Navia’s Clinical Research supports recruitment across Broward and Miami-Dade counties. Protocol-specific recruitment may include investigator practices, physician referrals, affiliated adult-care settings, the site’s outreach database, community engagement and IRB-approved digital outreach.
Identification → Pre-screening → Outreach → Scheduling → No-show reduction → Retention
Enrollment projections are made only after the Principal Investigator reviews the final inclusion and exclusion criteria and the site validates the accessible protocol-specific cohort.
Bilingual and Representative Research Access
Navia’s Clinical Research supports adult participants in English and Spanish through bilingual investigators and site personnel. Sponsor-provided or IRB-approved translated consent and recruitment materials are used when applicable. Additional languages may be supported through Sponsor-approved interpreter services when permitted by the protocol.
Recruitment sources and participant representation may be reviewed throughout the study when a Sponsor Diversity Action Plan or representativeness objective applies.
Facility & Equipment Capabilities
Dedicated adult outpatient research space
Private screening and consent areas
On-site monitoring space
Phlebotomy and specimen collection
Ambient centrifugation
Refrigerated centrifugation
Clinical refrigerator
−20°C frozen storage
Ultra-low-temperature storage
Dry-ice capability
Mortara ELI 150C/RX 12-lead ECG
Protocol-directed specimen processing and shipment
Remote-document workflows when permitted
External MRI and imaging coordination
Quest Diagnostics research-testing pathway through study-specific agreements
Equipment availability, calibration, qualification, temperature controls and protocol suitability are confirmed during feasibility and before study award.
Regulatory & Quality Readiness
Navia’s Clinical Research maintains processes supporting documented staff qualifications, protocol-specific training, Principal Investigator oversight, data integrity and Sponsor-required study startup.
Prepared to work with Sponsor-selected central IRBs
Active Advarra and Univo IRB site accounts
GCP and IATA training verified before delegation
Protocol-specific training before study duties begin
Delegation based on documented qualifications and competency
ALCOA+C documentation principles
ICH GCP E6(R3)-aligned oversight
Essential regulatory-document organization
SOP-supported study conduct
Sponsor/CRO portals supported
Sponsor-deployed EDC, ePRO and eConsent platforms supported after training
On-site and permitted remote-monitoring workflows
Dedicated Study Team
Our clinical research team includes two Principal Investigators, two nurse Clinical Research Coordinators, a dedicated clinical research phlebotomist and an investigational-product coordinator with pharmacy experience.
José Carlos Pedraza Navia —Registered Nurse, Site Manager & Clinical Research Coordinator
Olga Lidia Navia Corrales — Registered Nurse, Site Operations Director & Clinical Research Coordinator
Nayiver Pedraza Haquim — Clinical Research Phlebotomist & Medical Assistant
Mario Enrique Hernandez — Clinical Research Pharmacy Technician & Investigational Product Coordinator
Discuss a Study Opportunity
Contact Navia’s Clinical Research for protocol review, investigator alignment, feasibility assessment, or confirmation of site capabilities.
Initial feasibility inquiries are triaged within 48 hours, with a complete response targeted within five business days.